Key result
Balloon dilatation shows potential to treat acute intraprosthetic regurgitation immediately following SAPIEN-3 TAVI.
Why the study?
Acute intraprosthetic regurgitation is a rare but potentially devastating complication following transcatheter aortic valve implantation with limited treatment options.
Does balloon dilatation treat acute intraprosthetic regurgitation following SAPIEN-3 transcatheter aortic valve implantation?
Does balloon dilatation treat acute intraprosthetic regurgitation following SAPIEN-3 transcatheter aortic valve implantation?
Balloon dilatation may serve as a viable treatment option for the rare but devastating complication of acute intraprosthetic regurgitation following TAVI.
Acute intraprosthetic regurgitation is a rare but potentially devastating complication following the transcatheter aortic valve implantation; here, balloon dilatation could provide a potential treatment option for these patients.
No takes yet. Share an insight, caveat, or question.
Pal et al. (2021) studied this question. Balloon dilatation is a potential treatment option for acute intraprosthetic regurgitation immediately following SAPIEN-3 transcatheter aortic valve implantation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: